DGAP-News

Airbion GmbH: ​​​​​​​Airbion: German company challenges COVID-19 viruses and other ultrafine particles - Seite 2

Novel, patented VAPUR technology removes viruses, bacteria and ultrafine particles

The VAPUR technology developed by Professor Luthe and his team, with comprehensive patent protection, combines ultrasound, UV-C waves and heating to render ultrafine particles, viruses and bacteria suspended in the air harmless. Through the ultra-heating of these microparticles in the air stream, organic components are killed and denatured, through UV-C waves the RNA of bacteria and viruses is destroyed and ultrasound ensures that the virus shells are broken apart and the ultrafine particles are clumped. For humans, the air purification is not perceivable and completely harmless. No toxic chemicals are used and no toxic substances, such as ozone, are released. The current table-top device can purify around 90 m³ of ambient air per hour. A large device with a purification performance of around 400 m³ air per hour is in its final development and will probably be launched during the second half of 2021.

Experts attest unique principle of operation, also compared to ULPA and HEPA filters

Independent experts confirm that the VAPUR technology and the technology solutions of Airbion have a unique, positive effect. The renowned consulting company BlueXPRT attests in a current expert report: "The VAPUR technology is provably suited to eliminate ultrafine particles and hence COVID-19 viruses from the respiratory air. Even the most modern methods of particle removal were not able to cope with this so far." The Institute for Energy and Environmental Technology (IUTA), Duisburg, has certified in respect of Airbion: "The device provably kills SARS-CoV-2 by aggregation and UV-C irradiation." Aerosol Research and Engineering Labs, Inc. from the USA reaches the following conclusion in an impact study on a viral and a bacterial level: "In the field of virus killing an effectiveness of 99.943 was reached. The device reduces 99.831% of the bacterium Staphylococcus epidermidis [.] this device could hence reduce the risk of pulmonary infections". Consequently, Airbon clearly distinguishes itself from the existing filter solution, such as ULPA and HEPA filters. Many dangerous viruses, bacteria and particles are not completely captured by the existing commercial devices and, in addition, contaminated filters have to be replaced on a regular basis. As far as total costs are concerned, the VAPUR technology and the Airbion devices are hence superior to the conventional filter solutions.